A detailed history of Banco Bilbao Vizcaya Argentaria, S.A. transactions in Abb Vie Inc. stock. As of the latest transaction made, Banco Bilbao Vizcaya Argentaria, S.A. holds 380,706 shares of ABBV stock, worth $68.5 Million. This represents 0.88% of its overall portfolio holdings.

Number of Shares
380,706
Holding current value
$68.5 Million
% of portfolio
0.88%

Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$163.84 - $199.33 $62.4 Million - $75.9 Million
380,706 New
380,706 $75.2 Million
Q2 2024

Aug 06, 2024

BUY
$154.79 - $180.76 $711,105 - $830,411
4,594 Added 1.3%
358,987 $61.6 Million
Q1 2024

May 13, 2024

SELL
$159.82 - $182.1 $3.59 Million - $4.09 Million
-22,484 Reduced 5.97%
354,393 $64.5 Million
Q4 2023

Feb 13, 2024

SELL
$137.6 - $154.97 $113,932 - $128,315
-828 Reduced 0.22%
376,877 $58.4 Million
Q3 2023

Nov 08, 2023

BUY
$133.59 - $154.65 $736,882 - $853,049
5,516 Added 1.48%
377,705 $56.3 Million
Q2 2023

Aug 04, 2023

BUY
$132.51 - $164.9 $2.37 Million - $2.95 Million
17,879 Added 5.05%
372,189 $50.1 Million
Q1 2023

May 09, 2023

BUY
$144.61 - $166.54 $1.68 Million - $1.93 Million
11,589 Added 3.38%
354,310 $56.5 Million
Q4 2022

Feb 13, 2023

SELL
$138.31 - $165.87 $1.12 Million - $1.34 Million
-8,073 Reduced 2.3%
342,721 $55.4 Million
Q3 2022

Nov 14, 2022

BUY
$134.21 - $153.93 $2.27 Million - $2.61 Million
16,936 Added 5.07%
350,794 $47 Million
Q2 2022

Aug 08, 2022

BUY
$137.62 - $174.96 $1.4 Million - $1.78 Million
10,156 Added 3.14%
333,858 $51.1 Million
Q1 2022

May 12, 2022

BUY
$131.98 - $163.75 $17.3 Million - $21.4 Million
130,751 Added 67.76%
323,702 $52.8 Million
Q4 2021

Feb 15, 2022

BUY
$107.43 - $135.93 $4.41 Million - $5.58 Million
41,055 Added 27.03%
192,951 $26.2 Million
Q3 2021

Nov 12, 2021

SELL
$106.4 - $120.78 $1.72 Million - $1.95 Million
-16,153 Reduced 9.61%
151,896 $16.5 Million
Q2 2021

Aug 06, 2021

BUY
$105.21 - $117.21 $6.3 Million - $7.02 Million
59,897 Added 55.38%
168,049 $18.9 Million
Q1 2021

May 13, 2021

BUY
$102.3 - $112.62 $2.34 Million - $2.58 Million
22,893 Added 26.85%
108,152 $11.7 Million
Q4 2020

Feb 12, 2021

SELL
$80.49 - $108.67 $152,850 - $206,364
-1,899 Reduced 2.18%
85,259 $9.14 Million
Q3 2020

Nov 12, 2020

SELL
$85.91 - $100.83 $2.24 Million - $2.63 Million
-26,066 Reduced 23.02%
87,158 $7.63 Million
Q2 2020

Aug 12, 2020

BUY
$73.37 - $98.18 $653,726 - $874,783
8,910 Added 8.54%
113,224 $11.1 Million
Q1 2020

May 13, 2020

BUY
$64.5 - $97.79 $2.81 Million - $4.26 Million
43,530 Added 71.61%
104,314 $7.95 Million
Q4 2019

Feb 13, 2020

BUY
$72.13 - $90.25 $4.38 Million - $5.49 Million
60,784 New
60,784 $5.38 Million

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $318B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Banco Bilbao Vizcaya Argentaria, S.A. Portfolio

Follow Banco Bilbao Vizcaya Argentaria, S.A. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Banco Bilbao Vizcaya Argentaria, S.A., based on Form 13F filings with the SEC.

News

Stay updated on Banco Bilbao Vizcaya Argentaria, S.A. with notifications on news.